Latest Breaking News On - Research development at visgenx - Page 1 : comparemela.com

/PRNewswire/ Visgenx, Inc., a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced that the Company.

United statesWilliam pedrantiChristopher chavezVisgenx incSymposium programPrnewswire visgenx incCalifornia life sciencesResearch development at visgenxCalifornia lifeGene therapyAdvancing next generation therapiesWest coast symposiumAge related macular degenerationPrivate securities litigation reform actAll rights